Sorafenib Not Yet Recruiting Phase 2 Trials for Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03899428Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
NCT02129322Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1